ArticleIndian pacing and electrophysiology journal
Right jugular access as the primary approach for leadless pacemaker implantation in a center without cardiac surgery.
Article in Indian pacing and electrophysiology journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Leadless pacemaker implantation via right jugular approach in a patient with a bicaval valve system: a case report.European heart journal. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLeadless pacemaker (LP) implantation via the right internal jugular vein (RIJV) may overcome limitations of the femoral approach, reducing vascular complications, and improving navigation across the tricuspid valve. This study aimed to explore the feasibility and safety of RIJV LP implantation in a center without cardiac surgery.
methodsobservational study of all patients undergoing RIJV LP implantation at an institution without cardiac surgery.
resultsBetween April 2024 and June 2025, leadless pacemaker implantation via the RIJV was attempted in 34 patients, with a success rate of 85.3 % (n = 29). Implantation failed in five patients due to venous occlusion/stenosis (n = 4) or cardiac tamponade (n = 1). Among successful cases, fluoroscopy and procedure times averaged 7.3 ± 4.9 and 34.9 ± 13.7 minutes, respectively. Most implants (75.8 %) required a single deployment and were placed in the mid-septal area. No major access-related complications occurred. A learning curve was evident, with significant reduction in procedure time across tertiles. No significant differences were found in deployment attempts or final device position among tertiles.
conclusionsThe right jugular approach is feasible and safe, potentially expanding LP implantation among centers without cardiac surgery, though vascular assessment is crucial for patient selection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.